Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor with IC50 of 1.23 M, 20-fold more selective for VEGFR than PDGFR, lack of activity against EGFR, InsR and FGFR. Phase 3.
For research use only. We do not sell to patients.
| Name | Semaxanib (SU5416) |
|---|---|
| Iupac Chemical Name | 2H-Indol-2-one,3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-, (3Z)- |
| Synonyms | Semaxanib;SU5416 |
| Molecular Formula | C15H14N2O |
| Molecular Weight | 238.28 |
| Smile | Cc1cc([nH]c1/C=C\2/c3ccccc3NC2=O)C |
| InChiKey | WUWDLXZGHZSWQZ-WQLSENKSSA-N |
| InChi | InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8- |
| CAS Number | 204005-46-9 |
| MDL | MFCD09763655 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | yellow solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | 5mg/ml in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |